Blacktrace
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 9.6m | 10.7m | 14.2m | 13.0m | 5.1m | 5.5m | 7.8m |
% growth | 3 % | 11 % | 32 % | (8 %) | (61 %) | 7 % | 41 % |
Profit | <1m | <1m | <1m | 5.2m | (1.0m) | (1.8m) | (1.5m) |
% profit margin | - | - | 2 % | 40 % | (20 %) | (32 %) | (19 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
£400k | Grant | ||
£4.3m | Growth Equity VC | ||
* | N/A | Acquisition | |
Total Funding | €5.6m |
Related Content
Recent News about Blacktrace
EditBlacktrace Group is a dynamic and fast-growing science and technology company specializing in the design, development, and manufacturing of cutting-edge scientific products and technologies. The company serves clients in various fields including chemistry, biology, nanomaterial sciences, and microfluidics. Operating in the global market, Blacktrace leverages its expertise to turn scientific discoveries into commercial products. The business model revolves around continuous innovation and the development of new products, which are sold through market-leading brands. Revenue is generated through the sale of these advanced scientific products and technologies to research institutions, laboratories, and industrial clients. The company is open to acquisition opportunities but does not actively pursue them.
Keywords: scientific products, chemistry, biology, nanomaterial sciences, microfluidics, innovation, technology, commercial products, research, laboratories, industrial clients.